기계환기관련 폐렴치료 시 Aerosolized Colistin의 효과 및 안전성에 대한 체계적 문헌 고찰 및 메타분석 = Efficacy and Safety of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia: A Systematic Review and Meta-analysis

다국어 초록 (Multilingual Abstract)

Background: It is recommended to use aerosolized (AS) colistin in patients undergoing mechanical ventilation therapy as anadjunctive in the latest guidelines, in spite of high nephrotoxicity and limited studies. In this study, systematic reviews and metaanalyzeswere conducted to evaluate the safety and efficacy of AS colistin in patients with ventilator-associated pneumoniaMethods: Two authors independently searched related literature published from Pubmed and EMBASE until July 2016 and includeda study comparing adjunctive AS colistin with intravenous (IV) colistin monotherapy. The primary outcome was the clinical responserate, the secondary outcome was the overall mortality, and nephrotoxicity. The publication bias was evaluated using the Egger'stest. Results: Of the total 279 articles, nine were finally included in the final analysis. There was a significant difference between theadjunctive AS colistin group and the IV colistin monotherapy group for the treatment-response rate (odds ratio (OR), 1.56; 95% CI,1.14-2.14; p = 0.005; I2 = 36%), although there was no significant difference in overall mortality (OR, 0.77; 95% CI, 0.57-1.04; p =0.09; I2 = 20%). However, there was no significant difference between the two groups in nephrotoxicity (OR, 1.13; 95% CI, 0.74-1.74;p = 0.57; I2 = 4%). Conclusion: The addition of aerosolized colistin to IV colistin monotherapy showed better results in terms ofefficacy than IV colistin monotherapy and did not show any significant difference in terms of total mortality and nephrotoxicity.
Additional large-scale studies of this need to be verified.

참고문헌 (Reference)

1 Kalin G, "Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?" 18 (18): 872-877, 2012

2 Polat M, "Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children" 17 (17): 323-330, 2015

3 Valachis A, "The role of aerosolized colistin in the treatment of ventilator-associated pneumonia : a systematic review and metaanalysis" 43 (43): 527-533, 2015

4 Vincent JL, "The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee" 274 (274): 639-644, 1995

5 Wells G, "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses"

6 Chemical Sciences R, "The National Academies Collection: Reports funded by National Institutes of Health" National Academies Press (US)Copyright 2014 by the National Academy of Sciences 2014

7 Imberti R, "Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration" 138 (138): 1333-1339, 2010

8 Rattanaumpawan P, "Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria" 65 (65): 2645-2649, 2010

9 Siempos, II, "Predictors of mortality in adult patients with ventilator-associated pneumonia: a metaanalysis" 33 (33): 590-601, 2010

10 Kollef KE, "Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria" 134 (134): 281-287, 2008

11 Ratjen F, "Pharmacokinetics of inhaled colistin in patients with cystic fibrosis" 7 (7): 306-311, 2006

12 Pérez-Pedrero M, "Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients" 35 (35): 226-231, 2011

13 Jones RN, "Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia" 51 (51): S81-S87, 2010

14 Higgins JP, "Measuring inconsistency in meta-analyses" 327 (327): 557-560, 2003

15 Kalil AC, "Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society" 63 (63): e61-e111, 2016

16 Demirdal T, "Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?" 15 : 11-, 2016

17 Korbila IP, "Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study" 16 (16): 1230-1236, 2010

18 Livermore DM, "Has the era of untreatable infections arrived?" 64 (64): i29-i36, 2009

19 "Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia" 171 (171): 388-416, 2005

20 Rello J, "Epidemiology and outcomes of ventilator-associated pneumonia in a large US database" 122 (122): 2115-2121, 2002

21 Tumbarello M, "Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistinonly susceptible gram-negative bacteria" 144 (144): 1768-1775, 2013

22 Nation RL, "Colistin in the 21st century" 22 (22): 535-543, 2009

23 Li J, "Colistin : the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections" 6 (6): 589-601, 2006

24 Higgins J, "Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. 0 [updated March 2011]"

25 Egger M, "Bias in meta-analysis detected by a simple, graphical test" 315 (315): 629-634, 1997

26 Melsen WG, "Attributable mortality of ventilator-associated pneumonia : a meta-analysis of individual patient data from randomised prevention studies" 13 (13): 665-671, 2013

27 Sievert DM, "Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010" 34 (34): 1-14, 2013

28 Kofteridis DP, "Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study" 51 (51): 1238-1244, 2010

29 Palmer LB, "Aerosolized antibiotics in mechanically ventilated patients : delivery and response" 26 (26): 31-39, 1998

30 Doshi NM, "Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill : a retrospective study" 13 (13): 45-, 2013

31 Naesens R, "A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa" 11 : 317-, 2011

32 Ling LL, "A new antibiotic kills pathogens without detectable resistance" 517 (517): 455-459, 2015